Drug pricing
NPA asked to lobby wholesalers to limit generic price rises
Pharmacists’ representatives in Coventry have asked the National Pharmacy Association to help limit generic medicines prices, after being told that the prices pharmacists were paying were not being matched by the concession price paid out by the government.
The National Pharmacy Association (NPA) has been asked to lobby wholesalers to limit generic medicines price increases by a local pharmaceutical committee (LPC).
The call from Coventry LPC came after local community pharmacists told the LPC that the price they were paying for generic drugs was regularly not matched by the concession price paid out by the government.
Pharmacists at a Coventry LPC meeting held earlier in 2018 asked Nitin Sodha, NPA chair and an attendee at the meeting, to lobby for drug wholesalers not to sell any generic products higher than any concessionary price for the drugs negotiated between the Pharmaceutical Services Negotiating Committee and the Department for Health and Social Care.
A spokesperson for the NPA said the organisation recognised “the difficulties outlined by Coventry LPC and shares its concerns about generic medicine shortages and price increases”.
“Pharmacists have shown great professionalism and put patients first by continuing to supply medicines to patients promptly in good faith, despite knowing that they may be doing so at a loss,” they said.
“Our own surveys of NPA members confirm that the medicines supply chain, and certainly the matter of dispensing at a loss, remains an area of ongoing concern for pharmacy contractors.”
The NPA spokesperson added: “We continue to argue for a fair, competitive and sustainable generic medicines market, with a resilient and robust medicines supply chain that provides pharmacies with a rational and fair financial return.”
This article was updated on 12 September 2018 to reflect the fact that Coventry LPC had asked the NPA to lobby wholesalers rather than the government.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205433
Have your say
For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.
Recommended from Pharmaceutical Press
- Previous
- Next
Integrated Pharmacy Case Studies
Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.
£47.00Buy now
Pharmacy and the US Health Care System
A complete source of current information about the US health care system. Includes concise reports on trends, regulations, policy and finances.
£49.00Buy now
Paediatric Drug Handling
Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.
£33.00Buy now
Physicochemical Principles of Pharmacy
This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.
£48.00Buy now
Introduction to Pharmaceutical Calculations
Introduction to Pharmaceutical Calculations is an essential study aid for pharmacy students. The book contains worked examples and sample questions and answers.
£33.00Buy now
Print 
PDF
Readers' comments (1)
Stephen Willgress19 SEP 2018 8:41
I retired from a “generic” manufacturing company 4 years ago. My experience was that over time it was increasingly difficult and expensive to source API’s as manufacturers in Asia dropped out and those that remained reduced batch sizes etc. A single audit trip to Asia could double the cost of an API.
Unsuitable or offensive? Report this comment